Kuangli Photoelectric Technology Co Ltd (6431) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.026x

Based on the latest financial reports, Kuangli Photoelectric Technology Co Ltd (6431) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-15.32 Million ≈ $-482.63K USD) by net assets (NT$580.32 Million ≈ $18.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kuangli Photoelectric Technology Co Ltd balance sheet quality to measure how much of total assets are equity-financed.

Kuangli Photoelectric Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Kuangli Photoelectric Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Kuangli Photoelectric Technology Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Kuangli Photoelectric Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kuangli Photoelectric Technology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Ardiden Ltd
AU:ADV
-0.040x
Banxa Holdings Inc
V:BNXA
0.179x
OssDsign AB
ST:OSSD
-0.050x
Hyweb Technology Co Ltd
TWO:5212
0.387x
Qilian International Holding Group Limited
NASDAQ:BGM
-0.017x
Ai Energy Public Company Limited
BK:AIE
0.012x
Ailleron S.A.
WAR:ALL
0.037x
TransAct Technologies Incorporated
NASDAQ:TACT
-0.029x

Annual Cash Flow Conversion Efficiency for Kuangli Photoelectric Technology Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Kuangli Photoelectric Technology Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 6431 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$580.32 Million
≈ $18.28 Million
NT$-145.33 Million
≈ $-4.58 Million
-0.250x -76.57%
2024-12-31 NT$459.97 Million
≈ $14.49 Million
NT$-65.23 Million
≈ $-2.06 Million
-0.142x -26.88%
2023-12-31 NT$557.92 Million
≈ $17.58 Million
NT$-62.36 Million
≈ $-1.96 Million
-0.112x -713.48%
2022-12-31 NT$672.74 Million
≈ $21.19 Million
NT$-9.24 Million
≈ $-291.24K
-0.014x -147.04%
2021-12-31 NT$742.47 Million
≈ $23.39 Million
NT$21.69 Million
≈ $683.29K
0.029x +7.89%
2020-12-31 NT$313.81 Million
≈ $9.89 Million
NT$8.50 Million
≈ $267.67K
0.027x +110.40%
2019-12-31 NT$351.91 Million
≈ $11.09 Million
NT$-91.64 Million
≈ $-2.89 Million
-0.260x -365.09%
2018-12-31 NT$398.69 Million
≈ $12.56 Million
NT$-22.32 Million
≈ $-703.33K
-0.056x +50.59%
2017-12-31 NT$424.93 Million
≈ $13.39 Million
NT$-48.15 Million
≈ $-1.52 Million
-0.113x -764.22%
2016-12-31 NT$591.78 Million
≈ $18.64 Million
NT$10.10 Million
≈ $318.08K
0.017x -25.40%
2015-12-31 NT$919.58 Million
≈ $28.97 Million
NT$21.03 Million
≈ $662.59K
0.023x -90.93%
2014-12-31 NT$1.26 Billion
≈ $39.82 Million
NT$318.70 Million
≈ $10.04 Million
0.252x +49.77%
2013-12-31 NT$1.04 Billion
≈ $32.69 Million
NT$174.72 Million
≈ $5.50 Million
0.168x +23.01%
2012-12-31 NT$960.03 Million
≈ $30.25 Million
NT$131.41 Million
≈ $4.14 Million
0.137x --

About Kuangli Photoelectric Technology Co Ltd

TW:6431 Taiwan Household & Personal Products
Market Cap
$50.94 Million
NT$1.62 Billion TWD
Market Cap Rank
#21748 Global
#1336 in Taiwan
Share Price
NT$16.60
Change (1 day)
+1.84%
52-Week Range
NT$15.65 - NT$31.20
All Time High
NT$37.85
About

Kuangli Bio-Tech Holdings Co., Ltd. manufactures and sells panels for cover lens used in various electronic products in Taiwan and China. The company's products are used in mobile phone, PDA, instrument panels, digital camera windows, medical equipment, etc. It also engages in research and development, manufacturing, and sale of related biotech products, such as cosmetic, skin care, and health fo… Read more